Evidence map›Paper›PMID 26209532›Full record

ArticleInnate immunity2015

Cellular and molecular mechanisms of fungal β-(1→6)-glucan in macrophages.

Ilka Noss, Tammy R Ozment, Bridget M Graves, Michael D Kruppa, Peter J Rice, David L Williams

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Innate immunity, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.6field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. High M2/M1 Macrophage Ratio Observed in Nasal Polyps Formed in Allergic Fungal Rhinosinusitis.The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Ilka NossDepartment of Surgery, Quillen College of Medicine, East Tennessee State University, Johnson City, TN, USA Department of Pediatric Pneumology, Allergology and Neonatology, Hannover Medical School, Hannover, Germany.
Tammy R OzmentDepartment of Surgery, Quillen College of Medicine, East Tennessee State University, Johnson City, TN, USA Center for Inflammation, Infectious Disease and Immunity, East Tennessee State University, Johnson City, TN, USA.
Bridget M GravesDepartment of Surgery, Quillen College of Medicine, East Tennessee State University, Johnson City, TN, USA Center for Inflammation, Infectious Disease and Immunity, East Tennessee State University, Johnson City, TN, USA.
Michael D KruppaCenter for Inflammation, Infectious Disease and Immunity, East Tennessee State University, Johnson City, TN, USA.
Peter J RiceSkaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Aurora, CO, USA.
David L WilliamsDepartment of Surgery, Quillen College of Medicine, East Tennessee State University, Johnson City, TN, USA Center for Inflammation, Infectious Disease and Immunity, East Tennessee State University, Johnson City, TN, USA williamd@etsu.edu.
East Tennessee State University · USUniversity of Colorado Anschutz Medical Campus · US

Funding

Training Innate Immunity: A new approach to the treatment of SepsisR01GM119197 · NIGMS · EAST TENNESSEE STATE UNIVERSITY · PI SHERWOOD, EDWARD R, WILLIAMS, DAVID L. · 2016 to 2024
$4.6M
Innate Immunity and Cardiovascular Function in SepsisR01GM083016 · NIGMS · EAST TENNESSEE STATE UNIVERSITY · PI LI, CHUANFU, WILLIAMS, DAVID L. · 2009 to 2021
$3.8M
AMELIORATION OF SEPSIS BY MACROPHAGE ACTIVATIONR01GM053522 · NIGMS · EAST TENNESSEE STATE UNIVERSITY · PI WILLIAMS, DAVID L. · 1996 to 2015
$3.4M
NIGMS NIH HHS GM083016NIGMS NIH HHS GM53522NIGMS NIH HHS R01 GM053522NIGMS NIH HHS R01 GM083016NIGMS NIH HHS R01 GM119197
6 · The paper itself

Abstract

Over the last 40 yr, the majority of research on glucans has focused on β-(1→3)-glucans. Recent studies indicate that β-(1→6)-glucans may be even more potent immune modulators than β-(1→3)-glucans. Mechanisms by which β-(1→6)-glucans are recognized and modulate immunity are unknown. In this study, we examined the interaction of purified water-soluble β-(1→6)-glucans with macrophage cell lines and primary peritoneal macrophages and the cellular and molecular consequences of this interaction. Our results indicate the existence of a specific β-(1→6)-glucan receptor that internalizes the glucan ligand via a clathrin-dependent mechanism. We show that the known β-(1→3)-glucans receptors are not responsible for β-(1→6)-glucan recognition and interaction. The receptor-ligand uptake/interaction has an apparent dissociation constant (KD) of ∼ 4 µM, and was associated with phosphorylation of ERK and JNK but not IκB-α or p38. Our results indicate that macrophage interaction with β-(1→6)-glucans may lead to modulation of genes associated with anti-fungal immunity and recruitment/activation of neutrophils. In summary, we show that macrophages specifically bind and internalize β-(1→6)-glucans followed by activation of intracellular signaling and modulation of anti-fungal immune response-related gene regulation. Thus, we conclude that the interaction between innate immunity and β-(1→6)-glucans may play an important role in shaping the anti-fungal immune response.

Indexed as

Animalsbeta-GlucansCell LineGene Expression RegulationHumansImmunity, InnateMacrophagesMalasseziaMAP Kinase Signaling SystemMiceMice, Inbred C57BLMice, KnockoutNeutrophil ActivationReceptors, Pattern RecognitionSaccharomyces cerevisiaebeta-GlucansReceptors, Pattern RecognitionFungiglucaninnate immunitymacrophagesreceptor

Identifiers

PMID26209532
PMCPMC6231240
OpenAlexW1753922151

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.